Reilly Financial Advisors’s Charles River Laboratories CRL Stock Holding History

Reilly Financial Advisors’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$18K	Hold	47	–	–	﹤0.01%	583
2021 Q3	$19K	Hold	47	–	–	﹤0.01%	533
2021 Q2	$17K	Hold	47	–	–	﹤0.01%	578
2021 Q1	$14K	Hold	47	–	–	﹤0.01%	616
2020 Q4	$12K	Hold	47	–	–	﹤0.01%	586
2020 Q3	$11K	Hold	47	–	–	﹤0.01%	548
2020 Q2	$8K	Hold	47	–	–	﹤0.01%	623
2020 Q1	$6K	Hold	47	–	–	﹤0.01%	642
2019 Q4	$7K	Hold	47	–	–	﹤0.01%	681
2019 Q3	$6K	Hold	47	–	–	﹤0.01%	709
2019 Q2	$7K	Hold	47	–	–	﹤0.01%	721
2019 Q1	$7K	Buy	+47	New	+$6.17K	﹤0.01%	742
2016 Q3	–	Sell	-34	Closed	-$3K	–	844
2016 Q2	$3K	Buy	+34	New	+$2.8K	﹤0.01%	673

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Reilly Financial Advisors's CRL Position: Q4 2021 in Review

Reilly Financial Advisors held its Charles River Laboratories (CRL) position steady in Q4 2021 at 47 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #583.

Reilly Financial Advisors first reported a position in CRL in Q2 2016 and has held it in 13 quarters since. The position peaked at $19K in Q3 2021. 708 funds tracked by Wall St. Rank hold CRL as of Q4 2021.

Reilly Financial Advisors held 47 shares of Charles River Laboratories worth $18K as of Q4 2021.
Reilly Financial Advisors left its Charles River Laboratories share count unchanged in Q4 2021.
Charles River Laboratories made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #583 holding.
Reilly Financial Advisors first reported a position in Charles River Laboratories in Q2 2016 and has held it in 13 quarters since.
Reilly Financial Advisors's Charles River Laboratories position peaked at $19K in Q3 2021.
708 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.